Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
about
Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine developmentKinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvantVaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.Current advancements and potential strategies in the development of MERS-CoV vaccinesThymic Stromal Lymphopoietin Neutralization Inhibits the Immune Adjuvant Effect of Di-(2-Ethylhexyl) Phthalate in Balb/c Mouse Asthma ModelAdaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective responseThe adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primatesDevelopment of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical SynthesisInactivated influenza vaccines: recent progress and implications for the elderly.Design and synthesis of potent Quillaja saponin vaccine adjuvantsLeishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine InfectionThe dichotomy of pathogens and allergens in vaccination approachesCellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica Serovar Typhimurium to potentiate mucosal and systemic responses.Recent progress in adjuvant discovery for peptide-based subunit vaccinesDevelopment of a minimal saponin vaccine adjuvant based on QS-21Antibodies against Marinobacter algicola and Salmonella typhimurium flagellins do not cross-neutralize TLR5 activationA mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies.Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresolPreparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects.Synthesis and preclinical evaluation of QS-21 variants leading to simplified vaccine adjuvants and mechanistic probesAdjuvant Effect of Quillaja saponaria Saponin (QSS) on Protective Efficacy and IgM Generation in Turbot (Scophthalmus maximus) upon Immersion Vaccination.Mucosal vaccine adjuvants update.Vitamin A supplementation and retinoic acid treatment in the regulation of antibody responses in vivoPulmonary vaccine delivery.Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines.FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine.TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin BAugmentation of antibody responses by retinoic acid and costimulatory molecules.Towards identification of the mechanisms of action of parasite-derived peptide GK1 on the immunogenicity of an influenza vaccineA totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses.Experimental rabies vaccines for humans.Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems.Cancer vaccines. Any future?Lipid-based delivery of CpG oligodeoxynucleotides for cancer immunotherapy.Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant.Overview of computational vaccinology: vaccine development through information technology.Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.A combined fermentative-chemical approach for the scalable production of pure E. coli monophosphoryl lipid A.Quillaja Saponin Variants with Central Glycosidic Linkage Modifications Exhibit Distinct Conformations and Adjuvant Activities
P2860
Q21284959-2517E22E-8476-47C4-8E1C-1A09C4EC98F7Q24802323-01564A4E-7B5D-4DB9-90D5-88002D285050Q26796314-5612994C-F0B1-41CD-9B88-FA9A2A528FCBQ27012578-FF97C03A-FD0E-422A-8EBA-28BDC9A03868Q27334146-10380A2A-B53A-476B-9F9A-5F727534B219Q28476049-2DBFDB9E-36FA-4369-9DD2-2C392F2B93CFQ28729899-0669C146-9CE3-4826-A50F-59767C6AE179Q28829361-EFDAB7E9-3F9F-44D5-9F10-E323E3A44AABQ30399057-8FF6F99A-BDA3-4D62-9C7B-0F66F4F1C238Q33645835-290BF3A7-C182-43D1-B763-4621747EB1A1Q33737949-E21E6358-7100-4725-B144-36C558BAF7ACQ33909251-C4B27532-34D6-4C9B-9C57-44E1A77B05FFQ34033524-6B04A91D-56FD-47FF-AC39-5BD9C783D154Q34033780-198C191A-5F10-47BA-9DB3-5A1D6FFA9E3AQ34433407-B50487D3-630E-4D4E-B29A-B0FFF633EAA1Q34478993-E8774EF0-0E58-4441-8FD3-BF2D1324C16EQ34500312-420676FB-5EE0-4D3C-A4D4-5B579A1DEF42Q34518856-A184BBE4-BD3A-453F-A41C-C3F9E367F60AQ35539051-AF26BE22-9853-4A84-B2ED-3E1A44C62223Q35763466-CF5BED8F-057E-43D6-80F4-77B38D510319Q36216866-77EE439B-4038-499E-A9BD-79EE881C89EBQ36743593-90962C68-93CC-4D50-9A88-F1DF8993AFC5Q36758075-A017ABBE-71E0-4D54-9E0B-4405F2BDC21DQ36763133-AD012CF2-7219-4405-B80B-0997DD6F360AQ36780141-E263D8E5-246D-405A-81FB-87A8D87E2FDEQ36802325-8DE4BE80-FCAF-4CB0-A3C5-1486686A26BEQ37229935-CCEF02E2-E1AA-4410-B143-61E6614E5B63Q37259689-92726134-5997-4A15-A8A8-90B65EE6CB66Q37280181-B1D4663D-79A6-4647-8E32-601CF91BFFC4Q37349250-730A9C19-E268-4FFD-BA14-36E52FC4474CQ37585518-9E344B9E-27C7-4606-892B-81ADF5F249D1Q37798009-EDA254FB-9D08-4ACD-8AFD-56B022DD2E8FQ37867102-BCE0192D-2F6E-4D06-9B91-ADDB21F91C01Q37885282-1F0C3836-6C61-4153-8D53-87A7B23F5A20Q38177364-986F7308-8CEC-4DCA-8FB5-E51D09065696Q38282887-1AC365D0-51F6-4005-9B7D-D689F804EF41Q38298224-AFC1F388-AE51-4A0B-B2F5-55D24150A88AQ38461061-3F971569-E314-44F0-B5D7-8FCDA615ABF0Q38983228-E235C41F-454B-4FB4-A6AC-8B376DBDCCCCQ39236688-8700C876-3FB4-465C-9909-DD10FDD5B283
P2860
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
@ast
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
@en
type
label
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
@ast
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
@en
prefLabel
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
@ast
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
@en
P1433
P1476
Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
@en
P2093
Dante J Marciani
P304
P356
10.1016/S1359-6446(03)02864-2
P577
2003-10-01T00:00:00Z